By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Dipexium Pharmaceuticals 

22 Camelot Court

White Plains  New York  10603  U.S.A.
Phone: 914-949-3898 Fax: n/a


SEARCH JOBS



Segment
Pharmaceuticals





Company News
Dipexium Pharmaceuticals (DPRX) Initiates Second Of Two Pivotal Phase 3 Clinical Trials Of Locilex® In Patients With Mild Infections Of Diabetic Foot Ulcers 7/21/2014 10:37:45 AM
Dipexium Pharmaceuticals (DPRX) Announces Successful Completion Of Phase 1 Skin Irritation Trial Of Locilex® 7/17/2014 9:44:15 AM
Dipexium Pharmaceuticals (DPRX) Initiates Pivotal Phase 3 Clinical Trial Of Locilex® In Patients With Mild Infections Of Diabetic Foot Ulcers 7/17/2014 9:34:25 AM
Dipexium Pharmaceuticals (DPRX) To Ring The NASDAQ Stock Market Closing Bell 7/16/2014 11:02:37 AM
Dipexium Pharmaceuticals (DPRX) On Preliminary List Of Additions To Russell Microcap® Index 6/23/2014 8:54:21 AM
Dipexium Pharmaceuticals (DPRX) On Preliminary List Of Additions To Russell Microcap® Index 6/23/2014 7:29:00 AM
Dipexium Pharmaceuticals (DPRX) Closes Initial Public Offering 3/18/2014 10:53:42 AM
New York-Based Dipexium Pharmaceuticals (DPRX) Prices Upsized IPO At $12, Raises $33 Million 3/13/2014 6:41:05 AM
RRD International, LLC And Dipexium Pharmaceuticals Partner To Advance Locilex™ Through Clinical Trials 2/3/2014 9:43:03 AM
Dipexium Pharmaceuticals Provides Locilex™ Manufacturing Update 9/10/2013 9:44:52 AM
12
//-->